Hi We've got great news to report as we progress MB22001 through clinical trials. MB22001 is a proprietary titratable form of Lysergic Acid Diethylamide (LSD) designed specifically for take-home self administered microdosing.We're targeting Major Dep...

Hi I am delighted to share with you that MindBio Therapeutics Corp (CNSX: MBIO) has completed its landmark Phase 2a take home microdosing clinical trial in patients with Major Depressive Disorder.MindBio has achieved a significant milestone becoming...

Hi It's a very small dose of a proprietary form of LSD (lysergic acid diethylamide) for take-home microdosing (MB22001) that we have so much hope for in our Phase 2 clinical trials.On 14th February 2024 we will complete the final dose in our Phase 2a...

Hi MindBio is pleased to report that dosing is progressing well in its Phase 2a Depression trial using MB22001 (MindBio’s proprietary titratable form of LSD for take-home Microdosing). The final participant in this landmark clinical trial is nea...

Hi MindBio is pleased to report that dosing is progressing well in its Phase 2a Depression trial using MB22001 (MindBio’s proprietary titratable form of LSD for take-home Microdosing). To date, nineteen out of twenty participants have start...

Hi Approvals for take-home microdosing, could change everything!You need to see this video Stay Well!JUSTIN HANKACo-founderMindBio Therapeutics CorpCSE:MBIOPS. MindBio Therapeutics and Justin Hanka have been nominated in several industry awards...

Hi Approvals for take-home microdosing, could change everything!You need to see this video Stay Well!JUSTIN HANKACo-founderMindBio Therapeutics CorpCSE: MBIOPS. MindBio Therapeutics and Justin Hanka have been nominated in several industry awards...

Hi We've got some uplifting news from MindBio Therapeutics that we couldn't wait to share!Click Here For VideoHere's the news in brief: First Doses Taken! We've started dosing in our Phase 2B clinical trials in advanced stage cancer pa...

Hi I hope this email finds you well. We are thrilled to announce that MindBio Therapeutics has been nominated for the second year in a row for several prestigious awards at the upcoming Wonderland Conference in Miami this November.The nomination...

Hi We are thrilled to update you on the recent progress of our Phase 2 LSD-Microdosing for depression clinical trial. Click Here to Watch the Update1.     Landmark Clinical Trial: For the first time ever, we've...